NEW YORK , Aug. 9, 2024 /PRNewswire/ -- The global capillary electrophoresis market size is estimated to grow by USD 308 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 5.
66% during the forecast period. Increasing R and D expenditure is driving market growth, with a trend towards rise in proteomic research activities. However, presence of alternative technologies poses a challenge.
Key market players include Agilent Technologies Inc., Bio Rad Laboratories Inc., Bio Techne Corp.
, BIOPTIC.INC, Cleaver Scientific Ltd., Danaher Corp.
, Helena Laboratories Corp., LABGENE Scientific SA, Lumex Instruments, Merck KGaA, Perkin Elmer Inc., Prince Technologies B.
V., Promega Corp., QIAGEN NV, Sartorius AG, SEBIA SA , SERVA Electrophoresis GmbH, Sysmex Nederland B.
V., Thermo Fisher Scientific Inc., and WynSep.
Get a detailed analysis on regions, market segments, customer landscape, and companies- View the snapshot of this report Market Driver The demand for personalized medicines, particularly in the oncology therapeutic area, is driving the growth of the proteomics research market. Proteins play crucial roles in the body, and defects in their structures can lead to various disorders and conditions. Personalized medicines offer targeted drug development opportunities by identifying and studying protein expressions.
Pharmaceutical companies are increasingly shifting towards personalized medicines due to their potential for better patient manageme.